Urokinase type plasminogen activator receptor (uPAR) as a new therapeutic target in cancer

The urokinase (uPA)-type plasminogen activator receptor (uPAR) is a GPI-anchored receptor that focuses urokinase (uPA) proteolytic activity on the cell surface. uPAR also regulates cell adhesion, migration and proliferation, protects from apoptosis and contributes to epithelial mesenchymal transitio...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Transl Med UniSa
Prif Awduron: Montuori, Nunzia, Pesapane, Ada, Rossi, Francesca W, Giudice, Valentina, De Paulis, Amato, Selleri, Carmine, Ragno, Pia
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Università di Salerno 2016
Pynciau:
Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5120746/
https://ncbi.nlm.nih.gov/pubmed/27896223
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg